Jpmorgan Chase & Co - Jun 30, 2025 SCHEDULE 13G Report for Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value
Symbol: KPTI
Shares outstanding: 8.66M shares
Disclosed Ownership: 450K shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Date filed: 7/16/2025, 09:34 AM
Date of event: Jun 30, 2025
Next filing: Oct 17, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	5.2%	450K	450K	0	Rachel Tsvaygoft	Vice President